MigraineMend
Natural health product licensed in Canada
- Licence holder
- Vitamin-One Formulas Ltd
- NPN or DIN-HM
- 80078362
- Status
- Active licence
- Licence date
- 13 June 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine-5-phosphate | 200 milligramme | 400,000 µg |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 100 milligramme | Not calculated |
| Magnésium Source : Glycinate de magnésium | 60 milligramme | 120,000 µg |
Non-medicinal ingredients
Cellulose gum, silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 days |
Uses authorised in Canada
Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic. Use to prevent riboflavin deficiency. Helps to prevent magnesium deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. Consult a health care practitioner prior to use, if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen.
- Effets indésirables connus
Itching and or prickling sensation may occur, in which case; decrease intake and contact a health care practitioner. Hypersensitivity has been known to occur; in which case, discontinue use. Some people may experience diarrhoea.
Source
Official Health Canada record, licence 80078362
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.